CARBOGEN AMCIS anounces plan to restructure

Switzerland-based CARBOGEN AMCIS AG, a pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, has advised its employees and the authorities today of its plans for restructuring the Swiss company's operations in Bubendorf (BL), Aarau (AG) and Hunzenschwil (Neuland, AG). The company finds itself forced to take this step on the grounds of the inadequate profitability brought about by the strong Swiss franc and the delayed effects of the financial crisis. The company currently has approximately 350 employees in Switzerland.